home / stock / nuro / nuro quote
Last: | $4.33 |
---|---|
Change Percent: | -7.4% |
Open: | $3.92 |
Close: | $4.33 |
High: | $4.4465 |
Low: | $3.92 |
Volume: | 254,345 |
Last Trade Date Time: | 04/19/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$4.33 | $3.92 | $4.33 | $4.4465 | $3.92 | 254,345 | 04-19-2024 |
$3.65 | $3.7 | $3.65 | $3.805 | $3.55 | 10,039 | 04-18-2024 |
$3.57 | $3.615 | $3.57 | $3.615 | $3.51 | 10,685 | 04-17-2024 |
$3.51 | $3.53 | $3.51 | $3.5555 | $3.51 | 5,881 | 04-16-2024 |
$3.52 | $3.69 | $3.52 | $3.69 | $3.512 | 7,400 | 04-15-2024 |
$3.73 | $3.72 | $3.73 | $3.85 | $3.6901 | 20,637 | 04-12-2024 |
$3.85 | $3.7 | $3.85 | $3.85 | $3.7 | 9,128 | 04-11-2024 |
$3.69 | $3.8 | $3.69 | $3.85 | $3.6601 | 15,375 | 04-10-2024 |
$3.8 | $3.85 | $3.8 | $3.945 | $3.8 | 18,875 | 04-09-2024 |
$3.8 | $3.8 | $3.8 | $3.98 | $3.75 | 10,897 | 04-08-2024 |
$3.83 | $3.8701 | $3.83 | $3.9 | $3.73 | 14,408 | 04-05-2024 |
$3.9066 | $3.79 | $3.9066 | $3.94 | $3.79 | 12,623 | 04-04-2024 |
$3.85 | $4.025 | $3.85 | $4.025 | $3.83 | 23,250 | 04-03-2024 |
$3.96 | $3.965 | $3.96 | $4.0256 | $3.9 | 9,593 | 04-02-2024 |
$4.06 | $4.2 | $4.06 | $4.2 | $4.035 | 6,205 | 04-01-2024 |
$4.25 | $4.19 | $4.25 | $4.2783 | $4.12 | 9,178 | 03-29-2024 |
$4.25 | $4.19 | $4.25 | $4.2783 | $4.12 | 9,178 | 03-28-2024 |
$4.16 | $4.1 | $4.16 | $4.18 | $4.01 | 2,753 | 03-27-2024 |
$4 | $4.1697 | $4 | $4.1697 | $4 | 6,415 | 03-26-2024 |
$4.08 | $4.08 | $4.08 | $4.19 | $4.08 | 16,159 | 03-25-2024 |
News, Short Squeeze, Breakout and More Instantly...
Joshua S. Horowitz joins Board of DirectorsAt-the-market equity facility terminated WOBURN, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- NeuroMetri...
NeuroMetrix, Inc. (NASDAQ: NURO) is one of today's top gainers. The company's shares have moved 18.2% on the day to $4.3. NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeu...
Joshua S. Horowitz joins Board of Directors At-the-market equity facility terminated WOBURN, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (NASDAQ: NURO) today announced two steps to enhance shareholder value following feedback and recommendations from one of its l...